1. Home
  2. SER vs HNNA Comparison

SER vs HNNA Comparison

Compare SER & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • HNNA
  • Stock Information
  • Founded
  • SER 2017
  • HNNA 1989
  • Country
  • SER United States
  • HNNA United States
  • Employees
  • SER N/A
  • HNNA N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • HNNA Investment Managers
  • Sector
  • SER Health Care
  • HNNA Finance
  • Exchange
  • SER Nasdaq
  • HNNA Nasdaq
  • Market Cap
  • SER 61.5M
  • HNNA 73.8M
  • IPO Year
  • SER 2018
  • HNNA N/A
  • Fundamental
  • Price
  • SER $7.71
  • HNNA $10.18
  • Analyst Decision
  • SER
  • HNNA
  • Analyst Count
  • SER 0
  • HNNA 0
  • Target Price
  • SER N/A
  • HNNA N/A
  • AVG Volume (30 Days)
  • SER 21.6K
  • HNNA 9.6K
  • Earning Date
  • SER 08-09-2024
  • HNNA 12-04-2024
  • Dividend Yield
  • SER N/A
  • HNNA 5.40%
  • EPS Growth
  • SER N/A
  • HNNA 25.53
  • EPS
  • SER N/A
  • HNNA 0.80
  • Revenue
  • SER $3,172,500.00
  • HNNA $27,126,000.00
  • Revenue This Year
  • SER N/A
  • HNNA N/A
  • Revenue Next Year
  • SER N/A
  • HNNA N/A
  • P/E Ratio
  • SER N/A
  • HNNA $12.41
  • Revenue Growth
  • SER 2368.87
  • HNNA 11.90
  • 52 Week Low
  • SER $5.85
  • HNNA $6.33
  • 52 Week High
  • SER $25.00
  • HNNA $11.99
  • Technical
  • Relative Strength Index (RSI)
  • SER 57.44
  • HNNA 57.14
  • Support Level
  • SER $6.76
  • HNNA $9.20
  • Resistance Level
  • SER $8.14
  • HNNA $10.00
  • Average True Range (ATR)
  • SER 0.51
  • HNNA 0.30
  • MACD
  • SER 0.12
  • HNNA 0.00
  • Stochastic Oscillator
  • SER 79.62
  • HNNA 73.74

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced and fixed income products. It provides investment advisory services and shareholder services to the Hennessy Funds. Its investment advisory services include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities in accordance with the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

Share on Social Networks: